Dharam Ablashi
Dr. Ablashi is a co-discoverer of the HHV-6 virus, the Scientific Director of the HHV-6 Foundation and Chair of the Scientific Advisory Committee. Dr. Ablashi was Coordinator of DNA Virus Studies at the National Cancer Institute before becoming Director of Herpesvirus Programs at Advanced Biotechnologies. An Adjunct Professor in microbiology at the Georgetown University School of Medicine, he co-edited the book Human Herpesvirus 6 and has authored or co-authored over 300 journal articles on herpes viruses. He was a co-founder of the International Association for Research on Epstein-Bar Virus and Associated Diseases and was also a co-founder and former President of the International Association for Chronic Fatigue Syndrome or IACFS.

Louise G. Chatlynne, PhD
Advisor
Dr. Chatlynne helped set up the laboratories of Retrovirology Department at Walter Reed Army Institute of Research and designed the first usable ELISA test for HHV-8 antibodies. She worked for many years in industry working on viral reagents and doing in vitro antiviral testing. Instead of retiring, she is contributing her time to the HHV-6 Foundation to do literature research and to assist scientists in preparing their scientific findings for publication.

Tuan Phan
Tuan received his B.S. degree in Molecular Biology-Biochemistry from the University of California, Santa Barbara. During his time at UCSB, he performed research on mussels in the Marine Biotechnology Laboratory. Tuan has published a number of papers on HHV-6 including a meta-analysis on HHV6B reactivation and subsequent  aGVHD, a review of HHV-6B in liver transplantation and a review of the role of HHV-6B infection on T cell reconstitution. Tuan currently attends Tulane Medical School.

Eva Eliassen
Eva received a Bachelor of Science degree in Molecular, Cellular, and Developmental Biology with a minor in Swedish from the University of Washington in Seattle. She has also spent time testing recreational waters for the presence of antibiotic-resistant E. coli in and around Stockholm, Sweden, and through the Foundation, she has performed experiments to characterize the effects of heparin on HHV-6. Currently, Eva is preparing for medical school while training her wild mustang. Eva has published several review articles on HHV-6 and will attend medical school in the fall.